Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

By O. Abe, R. Abe, K. Enomoto, K. Kikuchi, H. Koyama, H. Masuda, Y. Nomura, K. Sakai, K. Sugimachi, T. Tominaga and 324 more. The Lancet, 2005

7,387 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/5d3c3c6d84980ac97932062ee59efc76998b7dde

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. J. Massagué
2. A. Stanisławek
3. Marcin Czeczelewski
4. Sergiusz Łukasiewicz
5. Robert Sitarz
6. J. Baj
7. Jichun Yang
8. Alicja Forma

In Oncology

1. X. Zhang
2. Larry Norton
3. J. Massagué
4. C. Hudis
5. R. Weinberg
6. Y. Fouad
7. C. Aanei
8. E. Hay

In Pathology and Forensic Medicine

1. A. Stanisławek
2. Marcin Czeczelewski
3. Sergiusz Łukasiewicz
4. Robert Sitarz
5. J. Massagué
6. J. Baj
7. Alicja Forma

Citations in the corpus

• Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review (2021, background): “Endocrinal therapy combined with chemotherapy is associated with the reduction of mortality rates amongst breast cancer patients [294].”